• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension

  • in Cardiovascular
  • — 10 Feb, 2007
GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension
AudioMedica News
GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension
GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-236"/>
Christopher Gray

CHRISTOPHER GRAY, University of Newcastle

REFERENCE: Abstract No. LB2
Treating high blood sugar in the acute phases of stroke doesn’t reduce risk of death or severe disability, the GIST – UK (Glucose Insulin in Stroke Trial) has found. This is despite other trials reporting that high glucose levels are associated with increased risk of stroke. Investigators also found that treating glucose levels aggressively lowered blood pressure. To discuss this surprise result, and the background to the trial, Helen Morant talked to Chris Gray.

[audio:https://www.audiomedica.com/podcasting/cardio/020709_chris_gray.mp3]

You may also like...

  • Deepak Bhatt SAVOR-TIMI 53 study: saxagliptin had better glucose control than placebo but no cardiovascular benefit 22 Sep, 2013
  • Patients with High Restenosis Risk Benefit More from Drug Eluting Stents Patients with High Restenosis Risk Benefit More from Drug Eluting Stents 5 Sep, 2007
  • LDL-How Low? LDL-How Low? 4 Sep, 2008
  • Protective Cardiovascular Benefit for Women on HRT For Natural Menopause Protective Cardiovascular Benefit for Women on HRT For Natural Menopause 6 Nov, 2007

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story “NIHSS-Plus”: Improvement on National Institutes of Health Stroke Scale?
  • Next story Thrombectomy For Acute Stroke: Results of the Multi MERCI Trial
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Microbiome Diversity Key To Survival After…
    • Ibrutinib: New Frontline Standard for Chronic…
    • Radiotherapy Cuts BRCA-Associated Contralateral…
    • Pembrolizumab: No Survival Gains Second Line In…
    • Genomic-led AML Clinical Decision Making Within Seven Days
  • Home
  • Cardiovascular
  • GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension

© COPYRIGHT 2020 AUDIOMEDICA.COM.